Robert Zweiker

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 761 citations

Endovascular Technique, Cardiovascular Disease, Randomised Superiority Trial +8

Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial

Dirk Sibbing, Dániel Aradi, Claudius Jacobshagen et al. · The Lancet · 2017 · 571 citations · Full text

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +11

Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial

Raban Jeger, Ahmed Farah, Marc‐Alexander Ohlow et al. · The Lancet · 2018 · 425 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Coronary Unit +6

Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial

Raban Jeger, Ahmed Farah, Marc‐Alexander Ohlow et al. · The Lancet · 2020 · 243 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Drug-coated Balloons +6

Influence of beta-blockers on melatonin release

Kurt Stoschitzky, A. Sakotnik, P. Lercher et al. · European Journal of Clinical Pharmacology · 1999 · 210 citations

Sleep, Melatonin Release, Medicine +5